EW
53
-2
IPG
49
2
XEL
53
-2
AAPL
64
11
DG
14
-3
ADM
30
-3
CMG
69
-4
NDAQ
50
-6
EXPD
37
-2
UNP
43
3
KMX
66
-2
CSCO
61
-3
KR
57
-6
AVB
57
-2
LEN
45
3
WFC
58
-2
MCO
74
-3
ACN
45
-4
EL
34
-3
AAL
59
-4
EW
53
-2
IPG
49
2
XEL
53
-2
AAPL
64
11
DG
14
-3
ADM
30
-3
CMG
69
-4
NDAQ
50
-6
EXPD
37
-2
UNP
43
3
KMX
66
-2
CSCO
61
-3
KR
57
-6
AVB
57
-2
LEN
45
3
WFC
58
-2
MCO
74
-3
ACN
45
-4
EL
34
-3
AAL
59
-4
Financhill
Back

Silence Therapeutics PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
36

SLN
Silence Therapeutics PLC

Last Price:
6.50
Seasonality Move:
5.8%
Sell
32

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.59
Seasonality Move:
29.16%
Sell
36
Silence Therapeutics PLC (SLN) is a Sell

Is Silence Therapeutics PLC a Buy, Sell or Hold?

  • The current Silence Therapeutics PLC [SLN] share price is $6.45. The Score for SLN is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SLN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.58. The Score for ADAP is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SLN Stock Price Chart

What is Silence Therapeutics PLC's stock price today?

  • The Silence Therapeutics PLC share price today is $6.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLN is experiencing selling pressure, which indicates risk of future bearish movement.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.

SLN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.03 Sell
Relative Strength Index (14 RSI): 24.74 Sell
Chaikin Money Flow: -179747 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.97 - 13.13) Sell
Bollinger Bands (100): (11.75 - 20.29) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 32.52 Sell
Chaikin Money Flow: -297165 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Sell
Bollinger Bands (100): (0.72 - 1.14) Sell

SLN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.48 Sell
20-day SMA: 7.91 Sell
50-day SMA: 13.91 Sell
200-day SMA: 18.8 Sell
8-day EMA: 7.22 Sell
20-day EMA: 8.85 Sell
50-day EMA: 12.29 Sell
200-day EMA: 16.33 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.64 Sell
20-day SMA: 0.66 Sell
50-day SMA: 0.75 Sell
200-day SMA: 1.06 Sell
8-day EMA: 0.63 Sell
20-day EMA: 0.67 Sell
50-day EMA: 0.76 Sell
200-day EMA: 0.95 Sell

Silence Therapeutics PLC Earnings Growth & SLN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $0.02 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and a decrease next year of $0.33 per share.

Silence Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):